Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...

Asthma and COPD share similar breathing symptoms, often leading to confusion and misdiagnosis. Know key differences, risks of ...

Cardiovascular diseases and diabetes are some of the most common coexisting conditions in COPD. Shared risk factors and overlapping physiological processes likely contribute to the high rate of ...

COPD may originate from chronic bronchitis, which inflames the airways, or from emphysema, which damages the lung air sacs. Key indicators of COPD may include persistent breathing changes such as ...

In our comprehensive fellowship program, you will receive a broad range of hands-on clinical experience and individualized instruction from nationally-known physicians and investigators in a collegial ...